Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eleven Biotherapeutics, Inc. | 1,390,712 | reported | 13 Jun 2016 | tx 2−1,042,000 |
| Mirati Therapeutics, Inc. | 287,866 | reported | 11 Aug 2023 | tx 7+1,258,973−260,292 |
| SOPHIRIS BIO INC. | 246,153 | reported | 16 Aug 2013 | tx 2+1,600,000 |
| Tango Therapeutics, Inc. | 108,793 | reported | 02 Jul 2024 | tx 12+2,815,579−809,731 |
| iTeos Therapeutics, Inc. | 2,517 | reported | 04 Jan 2022 | tx 14−700,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Jun 2024 | SALE | Tango Therapeutics, Inc. | 29,000 | 8.57 USD | |
| 01 Jul 2024 | SALE | Tango Therapeutics, Inc. | 110,731 | 8.87 USD | |
| 02 Jul 2024 | SALE | Tango Therapeutics, Inc. | 95,000 | 8.68 USD | |
| 06 Jun 2024 | SALE | Tango Therapeutics, Inc. | 63,000 | 7.24 USD | |
| 07 Jun 2024 | SALE | Tango Therapeutics, Inc. | 77,000 | 6.88 USD | |
| 03 May 2024 | SALE | Tango Therapeutics, Inc. | 60,000 | 7.61 USD | |
| 02 May 2024 | SALE | Tango Therapeutics, Inc. | 75,000 | 7.56 USD | |
| 01 May 2024 | SALE | Tango Therapeutics, Inc. | 75,000 | 7.43 USD | |
| 09 Oct 2023 | SALE | Tango Therapeutics, Inc. | 50,000 | 9.91 USD | |
| 09 Oct 2023 | SALE | Tango Therapeutics, Inc. | 175,000 | 9.97 USD | |
| 11 Aug 2023 | PURCHASE | Mirati Therapeutics, Inc. | 1,201,440 | 27.80 USD | |
| 11 Aug 2023 | PURCHASE | Mirati Therapeutics, Inc. | 57,533 | 27.80 USD | first after silence |
| 11 Aug 2023 | PURCHASE | Tango Therapeutics, Inc. | 475,000 | 5.15 USD | |
| 11 Aug 2023 | PURCHASE | Tango Therapeutics, Inc. | 2,340,579 | 5.15 USD | deriv |
| 03 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 432,903 | 47.65 USD | anomaly |
| 03 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 39,481 | 49.37 USD | |
| 03 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 17,173 | 50.63 USD | |
| 03 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 23,353 | 47.63 USD | |
| 03 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 1,682 | 49.37 USD | |
| 03 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 731 | 50.63 USD | |
| 04 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 2,517 | 45.48 USD | |
| 04 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 9,366 | 43.36 USD | |
| 04 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 33,297 | 44.44 USD | |
| 04 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 7,483 | 45.48 USD | |
| 04 Jan 2022 | SALE | iTeos Therapeutics, Inc. | 29,623 | 41.84 USD |
1 purchase reported after at least 12 months of silence — most recent on 11 Aug 2023.